Aggressive therapy not necessary for low-grade, localised prostate cancer

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1487, 2005-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacotherapy for biochemical recurrences after therapy for localised prostate cancer

By Ornstein David K   Gaston Kris E  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 6, 2002-06 ,pp. : 657-669

Informa Healthcare

Access to resources Recommend Favorite

High-risk localised prostate cancer: multimodal treatment strategies combining neoadjuvant hormonal therapy and/or chemotherapy with radical prostatectomy

By Eastham James A  

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 2, 2003-11 ,pp. : 291-295

Informa Healthcare

Access to resources Recommend Favorite

Multimodal treatment strategies combining neoadjuvant hormonal therapy and/or chemotherapy with radical prostatectomy in high-risk localised prostate cancer

By Eastham James A  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 1, 2004-01 ,pp. : 39-46

Informa Healthcare

Access to resources Recommend Favorite

MRC PR07: A Randomised Trial of Hormone Therapy ± Radiotherapy in Advanced Localised Prostate Cancer (ISRCTN 24991896)*

By  

UroOncology, Vol. 2, Iss. 2, 2002-01 ,pp. : 59-61

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Association of very low prostate-specific antigen levels with increased cancer-specific death in men with high-grade prostate cancer

By Mahal Brandon A.   Aizer Ayal A.   Efstathiou Jason A.   Nguyen Paul L.  

Cancer, Vol. 122, Iss. 1, 2016-01 ,pp. : 78-83

Blackwell Publishing

Access to resources Recommend Favorite